Europe: Where is the drug discovery innovation?
Drug Discovery World
MAY 6, 2024
Mazzetti and Schneider give the example of T3 Pharmaceuticals, a University of Basel spin-off that developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. One such company, drawing on Vilnius’ gene editing expertise, is Caszyme, which was founded by Professor Šikšnys.
59 
Let's personalize your content